Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biora Therapeutics Inc BIOR

Healthcare Biotechnology
Biora Therapeutics, Inc. is a biotechnology company, which is focused on creating smart pills designed for targeted drug delivery to the gastrointestinal (GI) tract, and systemic, needle-free delivery of biotherapeutics. The Company’s pipeline includes two therapeutic delivery platforms: NaviCap and BioJet. The NaviCap, targeted oral delivery platform, which is designed to improve outcomes for... see more

Recent & Breaking News (NDAQ:BIOR)

Progenity Announces Closing of $40 Million Underwritten Public Offering

GlobeNewswire August 24, 2021

Progenity Announces Pricing of $40 Million Public Offering of Common Stock and Warrants

GlobeNewswire August 19, 2021

Progenity Announces Proposed Underwritten Public Offering of Common Stock and Warrants

GlobeNewswire August 19, 2021

Progenity Provides Corporate Update and Reports Second Quarter 2021 Financial Results

GlobeNewswire August 12, 2021

Progenity to Report Second Quarter 2021 Financial Results and Provide Corporate Update

GlobeNewswire August 5, 2021

Progenity Announces Successful Completion of Clinical Validation Study and Achievement of the Primary Endpoint for its Preeclampsia Rule-Out Test

GlobeNewswire July 29, 2021

Progenity Announces Appointment of Surbhi Sarna to its Board of Directors

GlobeNewswire June 30, 2021

(PROG) Long Term Investor Alert: Johnson Fistel Investigates Progenity; Should Management be Held Accountable for Investors Losses?

GlobeNewswire June 19, 2021

Progenity Establishes Inflammatory Bowel Disease Clinical Advisory Board

GlobeNewswire June 17, 2021

Progenity to Participate in the Raymond James 2021 Human Health Innovation Conference

GlobeNewswire June 15, 2021

NASDAQ: PROG Investor Notice: Update in Lawsuit against Progenity, Inc. announced by Shareholders Foundation

GlobeNewswire June 15, 2021

PROGENITY INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Progenity, Inc. - PROG

Business Wire June 11, 2021

Progenity Announces $40 Million Private Placement

GlobeNewswire June 10, 2021

Progenity Launches Strategic Transformation into Biotech Company, Eliminating Costs of Progenity Genetics Lab and Focusing on Robust, Innovative R&D Pipeline

GlobeNewswire June 2, 2021

Progenity Provides Results from Key Study for Its Targeted Therapeutics Program

GlobeNewswire May 26, 2021

Sean Lavin, MD, Joins Progenity as Vice President, Business Development, Strategy, and Investor Relations

GlobeNewswire May 25, 2021

Progenity Announces Poster Presentations at Digestive Disease Week 2021

GlobeNewswire May 24, 2021

Progenity Joins Global Call to Raise Awareness of Preeclampsia in Pregnancy on World Preeclampsia Day - May 22nd

GlobeNewswire May 21, 2021

Progenity Provides Corporate Update and Reports First Quarter 2021 Financial Results

GlobeNewswire May 13, 2021

Progenity Provides Preliminary Results from Key Studies for its Targeted Therapeutics Program

GlobeNewswire May 12, 2021